🇺🇸 FDA
Patent

US 10610486

Sustained release formulation of a non-steroidal anti-inflammatory drug

granted A61KA61K31/196A61K31/407

Quick answer

US patent 10610486 (Sustained release formulation of a non-steroidal anti-inflammatory drug) held by Pacira Pharmaceuticals, Inc. expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/196, A61K31/407, A61K31/5415, A61K9/127